70P Impact of TP53/KRAS mutations on overall survival of metastatic non-small cell lung cancer patients (pts) treated with systemic first-line therapy
Novella, S. Rubio, Cobo, A., Montes, A., Lopez, J. Soler, Rondan, M. Arnal, Palanca, S. Noguera, Tena, I., Miguel, J., Navarro, B., Domingo, I., Esteban, S. Cases, Díaz, M., Andrade, P., Rosello, E., Santander, J.R. Lazaro, Estelles, D. Lorente, Hernández, A. Sánchez
Published in Journal of thoracic oncology (01.04.2023)
Published in Journal of thoracic oncology (01.04.2023)
Get full text
Journal Article